Cargando…
Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients
PURPOSE: Dexrazoxane has been used as an effective cardioprotector against anthracycline cardiotoxicity. This study intended to analyze cardioprotective efficacy and secondary malignancy development, and elucidate risk factors for secondary malignancies in dexrazoxane-treated pediatric patients. MAT...
Autores principales: | Kim, Hyery, Kang, Hyoung Jin, Park, Kyung Duk, Koh, Kyung-Nam, Im, Ho Joon, Seo, Jong Jin, Lee, Jae Wook, Chung, Nack-Gyun, Cho, Bin, Kim, Hack Ki, Lee, Jae Min, Hah, Jeong Ok, Lee, Jun Ah, Lee, Young Ho, Park, Sang Kyu, Baek, Hee Jo, Kook, Hoon, Kim, Ji Yoon, Kim, Heung Sik, Kim, Hwang Min, Chueh, Hee Won, Park, Meerim, Yoon, Hoi Soo, Lee, Mee Jeong, Choi, Hyoung Soo, Ahn, Hyo Seop, Kawano, Yoshifumi, Park, Ji Won, Hahn, Seokyung, Shin, Hee Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333985/ https://www.ncbi.nlm.nih.gov/pubmed/29764117 http://dx.doi.org/10.4143/crt.2017.457 |
Ejemplares similares
-
Korean parents’ perceptions of the challenges and needs on school re-entry during or after childhood and adolescent cancer: a multi-institutional survey by Korean Society of Pediatric Hematology and Oncology
por: Lee, Jun Ah, et al.
Publicado: (2019) -
Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte
por: Choi, Hyoung Soo, et al.
Publicado: (2019) -
Epidemiological Study of Hereditary Hemolytic Anemia in the Korean Pediatric Population during 1997–2016: a Nationwide Retrospective Cohort Study
por: Shim, Ye Jee, et al.
Publicado: (2020) -
Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
por: Choi, Hyoung Soo, et al.
Publicado: (2010) -
Treatment outcomes in children with Burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution
por: Park, Eun Sil, et al.
Publicado: (2011)